RankingsPricing
  1. US-listed companies
  2. VERTEX PHARMACEUTICALS INC
  3. Financials
  4. Return on Assets

VERTEX PHARMACEUTICALS INC【VRTX】

Market cap
$119.1B
P/E ratio
SummaryFinancials
Period EndReturn on Assets (Million USD)YoY (%)
Dec 31, 2024-2.4-113.38%
Dec 31, 202317.7-15.83%
Dec 31, 202221+13.12%
Dec 31, 202118.6-31.16%
Dec 31, 202027+67.20%
Dec 31, 201916.2-62.27%
Dec 31, 201842.8+423.59%
Dec 31, 20178.2-363.02%
Dec 31, 2016-3.1-86.49%
Dec 31, 2015-23-27.47%
Dec 31, 2014-31.7+81.06%
Dec 31, 2013-17.5+750.97%
Dec 31, 2012-2.1-198.10%
Dec 31, 20112.1

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)